Lv11
38 积分 2023-05-17 加入
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
17天前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
1个月前
已完结
Empagliflozin (BI 10773), a Potent and Selective SGLT2 Inhibitor, Induces Dose‐Dependent Glucosuria in Healthy Subjects
1个月前
已完结
FRI-156 DR10624, a novel FGF21R/GCGR/GLP-1R triple agonist, significantly reduced liver fat and improved hepatic and metabolic biomarkers in a phase 2 study of patients with severe hypertriglyceridemia
1个月前
已完结
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
2个月前
已完结
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
2个月前
已完结
Phase II PARAMOUNT trial of LCZ696
2个月前
已完结
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial
2个月前
已完结
Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial
2个月前
已完结
The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
2个月前
已完结
皖公网安备34019202002308
